Medication Management for Muscle Relaxation

Introduction to Methocarbamol

Methocarbamol elimination is significantly impaired in patients with liver and kidney disease, consider dose reduction in these populations, and monitor for signs of drug accumulation 1
The Society for Perioperative Assessment and Quality Improvement (SPAQI) recommends holding methocarbamol on the day of surgical procedures due to its cardiovascular effects 1
Methocarbamol may interfere with pyridostigmine bromide effects, which is contraindicated in myasthenia gravis, and has sedative properties that could potentiate central nervous system depression 1

For patients with cardiovascular disease requiring muscle relaxation, consider less-sedating muscle relaxants (such as metaxalone) if appropriate, and use the lowest effective dose of methocarbamol if necessary 2, 1

Methocarbamol can cause bradycardia and hypotension as documented cardiovascular adverse effects, and should be used with caution in patients with cardiac conditions 1
Methocarbamol has several known cardiovascular effects, including bradycardia, hypotension, syncope, flushing, and thrombophlebitis, with hypotension being a documented adverse reaction 1
Methocarbamol may interact with other medications that affect cardiac function, and its sedative properties can enhance CNS depression, particularly when used with sedatives and anesthetic agents 1
Methocarbamol elimination is significantly impaired in patients with renal or hepatic impairment, potentially leading to drug accumulation and increased risk of adverse effects, and non-pharmacological approaches may be preferable for some patients 2, 1